As of Nov 22
| 0.00 / 0.00%|
The 20 analysts offering 12-month price forecasts for Bristol-Myers Squibb have a median target of 64.50, with a high estimate of 75.00 and a low estimate of 49.00. The median estimate represents a +5.50% increase from the last price of 61.14.
The current consensus among 24 polled investment analysts is to Hold stock in Bristol-Myers Squibb. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.